SUMMARY Thirty male patients with sexually acquired reactive arthritis (SARA) 
determinant HLA B27 in 66 % of patients, is widely recognised, as in other forms of reactive arthritis, but the cause of NGU and the exact nature of the relationship between NGU and SARA are uncertain. It is, however, a plausible hypothesis that antigens derived from the agents causing the urethritis are responsible for initiating inflammatory musculoskeletal and other lesions in genetically predisposed individuals.
Strong evidence has now accumulated from both human and animal studies that infection by Chlamydia trachomatis causes a substantial proportionperhaps about 50%-of cases of NGU,4-and we have therefore sought evidence that infection by this micro-organism may be important in the development of SARA. We have previously reported the isolation of C. trachomatis from the urethra of 5 unlikely that isolation of the micro-organism alone can either reflect the true rate of infection, as a detectable antibody response to C. trachomatis occurs in some patients with NGU from whom an isolate cannot be obtained,89 or indicate whether or not this infection is of special significance in the initiation of SARA. Moreover, since it is likely that specific immune responses and aspects of antigen handling play a central role in the development of this condition, we consider that an assessment of the immune response to C. trachomatis in patients with SARA may provide a crucial first step to the understanding of its pathogenesis.
We have therefore attempted to assess both the prevalence of C. trachomatis infection and also quantitative aspects of the humoral immune response to this micro-organism in SARA compared with uncomplicated urethritis, using a modification of the microimmunofluorescence method of Wang and Grayston,10 which provides a sensitive, specific, and reproducible method for detecting and quantifying the different immunoglobulin classes of antibody to chlamydiae in man.1' 12 Patients, materials and methods Fig. 3 ) on a simple arbitrary 0 to 5 scale. Fifteen patients with SARA who were first seen within 3 weeks of the onset of joint symptoms (mean 10 days) have been followed up throughout the course of their illness and for a variable period after cessation of all signs of disease activity. The mean duration of active rheumatic disease in these 15 patients was 13 6 weeks and the mean surveillance period was 36 5 weeks.
During the time of this study 555 men presenting to the venereology clinic with uncomplicated NGU were also studied. 2a) . Three of these had an 8-fold or greater rise in titre during the period of active joint disease and subsequently 6 patients, including these 3, had a 4-fold or greater fall in titre. The 2 remaining patients with elevated initial titres had no significant change during the period of surveillance. In contrast, no IgG antibody could be detected at any time during the course of disease in the sera of the remaining 7 patients (not shown). Six of the 8 chlamydial antibody-positive patients were also culture-positive while none of those without antibody were culturepositive.
Seven of the 15 SARA patients who were studied serially had IgM antibody in the intitial serum (Fig.  2b) , and 1 of these subsequently had a 4-fold rise in titre; 1 patient without detectable IgM antibody in the initial serum developed a peak titre if 1:16, and subsequently a significant reduction in titre was demonstrated in all 8, in 5 (mean 24 weeks). The duration of this response bore no relationship to the presence of active joint disease. In contrast titres of IgG antibody, though often raised at presentation, reached a peak at 1 to 10 weeks (mean 6 weeks) from the onset of arthritis. In spite of a gradual downward trend thereafter in most patients, in none did the titre of IgG serum antibody fall below 1:16 during the period of observation and in 4 patients elevated titres persisted for more than I year after cessation of all symptoms. The changes in titre of IgG and IgM antibody during the course of SARA are illustrated by results from a single patient (Fig. 3) .
The muscoluskeletal features of the 22 chlamydial antibody-positive patients did not differ in any way from those of the 8 others. (Fig. 2a) and IgM (Fig. 2b) (Fig. la) . The GMT of serum antibody in these groups was only 1:2-2, 1:2 2, 1:3-5, and 1:14 respectively, in marked contrast to that of 1:47 -5 in the SARA group m 88888 @ (Table 2 ). It is apparent from Fig. la during the period of active synovitis: all were found to be within ranges normally found in adults currently uninfected by these viruses.
Discussion
The importance of this study lies in its clear demonstration of an exaggerated humoral immune response to chlamydial antigens which appears to characterise a high proportion of, though not all, patients with SARA. Since the concept of reactive arthritis implies that tissue damage in affected areas is brought about by the action of antibodies, immune complexes, sensitised cells and/or other inflammatory mediators arising from the focus of infection, which in the case of SARA lies within the genital tract, this finding suggests that the organism C. trachomatis or antigens derived from it may play a central role in the initiation of SARA.
The isolation of C. trachomatis from the urethra of 36% of men with SARA is consistent with the earlier findings of Vaughan-Jackson et aL.,'7 who isolated the organism from 3 of 10 patients with Reiter's syndrome, but differs substantially from the 69% isolation rate found by Kousa et al.'8 in patients with Reiter's syndrome and active urethritis. Our isolation rate of 36 -5 % in men with uncomplicated NGU is consistent with other published data. [4] [5] [6] It is clear from other studies in which the microimmunofluorescence test or a modification of it has been used that raised titres of IgG antibody to C. trachomatis are found in 70-100% of isolatepositive men with NGU and that similar titres also occur in 21-44% of those in whom cultures are negative.12 19 20 Our data on both the SARA and The presence of antibody in synovial fluid raises the possibility of local production, which may in ttlrn indicate the presence of chlamydial antigens within the joint. In the absence of information on local antibody production in human arthritis in which micro-organisms are known to be present in the joint these data are impossible to interpret with certainty. However, the fact that antibody to influenza virus was distributed almost equally between serum and synovial fluid suggests that both types of antibody are derived from the circulation rather than from local intra-articular sources.
Thus it appears that C. trachomatis infection could be an initiating factor in approximately 50% of patients with SARA. The exaggerated antibody response to this organism in these patients may have very important pathogenetic implications, and this phenomenon certainly requires further study. Other trigger factors, however, remain to be identified. 
